Article Details

CAN-FITE BIOPHARMA GAINS ANALYST "BUY" DISTINCTION AND SIGNS NEW DISTRIBUTION ...

Retrieved on: 2021-05-12 13:30:00

Tags for this article:

Click the tags to see associated articles and topics

CAN-FITE BIOPHARMA GAINS ANALYST "BUY" DISTINCTION AND SIGNS NEW DISTRIBUTION .... View article details on HISWAI: https://www.benzinga.com/general/biotech/21/05/21082603/can-fite-biopharma-gains-analyst-buy-distinction-and-signs-new-distribution-agreements-for-its-le

Excerpt

Can-Fite BioPharma Ltd. (NYSE: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up